Jiangsu Hengrui Medicine
600276.SS
#502
Rank
ยฃ30.70 B
Marketcap
ยฃ4.81
Share price
-0.44%
Change (1 day)
-0.47%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Market capitalization of Jiangsu Hengrui Medicine (600276.SS)

Market cap: ยฃ30.70 Billion

As of September 2024 Jiangsu Hengrui Medicine has a market cap of ยฃ30.70 Billion. This makes Jiangsu Hengrui Medicine the world's 502th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Jiangsu Hengrui Medicine from 2000 to 2024

End of year Market Cap

Year Market cap Change
2024ยฃ30.70 B-3.78%
2023ยฃ31.90 B9.54%
2022ยฃ29.12 B-22.55%
2021ยฃ37.60 B-43.65%
2020ยฃ66.74 B59.84%
2019ยฃ41.75 B88.64%
2018ยฃ22.13 B0.56%
2017ยฃ22.01 B76.61%
2016ยฃ12.46 B24.69%
2015ยฃ9.99 B70.92%
2014ยฃ5.84 B13.14%
2013ยฃ5.16 B40.01%
2012ยฃ3.69 B9.39%
2011ยฃ3.37 B-23.08%
2010ยฃ4.38 B47.62%
2009ยฃ2.97 B46.58%
2008ยฃ2.02 B20.89%
2007ยฃ1.67 B139.49%
2006ยฃ0.70 B159.01%
2005ยฃ0.27 B34.8%
2004ยฃ0.20 B37.43%
2003ยฃ0.14 B-24.35%
2002ยฃ0.19 B-35.73%
2001ยฃ0.30 B-7.4%
2000ยฃ0.32 B

End of Day market cap according to different sources

On Sep 15th, 2024 the market cap of Jiangsu Hengrui Medicine was reported to be:

ยฃ30.70 Billion
by Yahoo Finance info icon info icon
ยฃ30.70 Billion
by CompaniesMarketCap info icon info icon